Yahoo
HKSE - Delayed Quote HKD

Sanai Health Industry Group Company Limited (1889.HK)

0.179 +0.001 (+0.56%)
At close: 3:53:25 PM GMT+8
Chart Range Bar
Loading chart for 1889.HK
  • Previous Close 0.178
  • Open 0.168
  • Bid 0.168 x --
  • Ask 0.179 x --
  • Day's Range 0.168 - 0.179
  • 52 Week Range 0.127 - 0.650
  • Volume 80,000
  • Avg. Volume 47,060
  • Market Cap (intraday) 27.369M
  • Beta (5Y Monthly) -1.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.140
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Jun 26, 2012
  • 1y Target Est --

Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People's Republic of China and Hong Kong. It operates through Pharmaceutical Products and Finance Leasing segments. The company is involved in development, manufacturing, marketing, and sales of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services. It also provides finance leasing services; and engages in the research, production, and sale of health products, functional foods, and skincare products in the field of soft capsule dosage form. Sanai Health Industry Group Company Limited was incorporated in 2006 and is based in Kwun Tong, Hong Kong.

www.1889hk.com

140

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1889.HK
64.20%
HANG SENG INDEX (^HSI)
8.21%

1-Year Return

1889.HK
60.22%
HANG SENG INDEX (^HSI)
10.06%

3-Year Return

1889.HK
87.86%
HANG SENG INDEX (^HSI)
33.19%

5-Year Return

1889.HK
95.23%
HANG SENG INDEX (^HSI)
5.99%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -23.59%

  • Return on Assets (ttm)

    -2.48%

  • Return on Equity (ttm)

    -7.99%

  • Revenue (ttm)

    82.6M

  • Net Income Avi to Common (ttm)

    -19.48M

  • Diluted EPS (ttm)

    -0.140

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    315.43M

  • Total Debt/Equity (mrq)

    25.03%

  • Levered Free Cash Flow (ttm)

    74.49M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: